These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12210408)

  • 1. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
    MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
    J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection.
    MacQuillan GC; Mamotte C; Reed WD; Jeffrey GP; Allan JE
    J Med Virol; 2003 Jun; 70(2):219-27. PubMed ID: 12696108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MxA and PKR expression in chronic hepatitis C.
    Giannelli G; Guadagnino G; Dentico P; Antonelli G; Antonaci S
    J Interferon Cytokine Res; 2004 Nov; 24(11):659-63. PubMed ID: 15684819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
    Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
    J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
    Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
    Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of clinical evidence for involvement of hepatitis C virus interferon-alpha sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses.
    Mihm S; Monazahian M; Grethe S; Meier V; Thomssen R; Ramadori G
    J Med Virol; 2000 May; 61(1):29-36. PubMed ID: 10745229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.
    Duarte-Rojo A; Fischer SE; Adeyi O; Zita D; Deneke MG; Selzner N; Chen L; Malespin M; Cotler SJ; McGilvray ID; Feld JJ
    J Viral Hepat; 2016 May; 23(5):340-7. PubMed ID: 26710754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C.
    Cheng JC; Yeh YJ; Huang YH; Liang KH; Chang ML; Lin CY; Yeh CT
    J Viral Hepat; 2012 Feb; 19(2):e154-62. PubMed ID: 22239513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.
    Walsh MJ; Jonsson JR; Richardson MM; Lipka GM; Purdie DM; Clouston AD; Powell EE
    Gut; 2006 Apr; 55(4):529-35. PubMed ID: 16299039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
    Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
    Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
    J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
    Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
    Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
    Persico M; Capasso M; Persico E; Svelto M; Russo R; Spano D; Crocè L; La Mura V; Moschella F; Masutti F; Torella R; Tiribelli C; Iolascon A
    Hepatology; 2007 Oct; 46(4):1009-15. PubMed ID: 17668875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.
    Hamdi N; El-Akel W; El-Serafy M; Esmat G; Sarrazin C; Abdelaziz AI
    Intervirology; 2012; 55(3):210-8. PubMed ID: 21597279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
    Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
    Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis.
    Leifeld L; Ramakers J; Schneiders AM; Dumoulin FL; Sterneck M; Müller A; Sauerbruch T; Spengler U
    J Pathol; 2001 Aug; 194(4):478-83. PubMed ID: 11523057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.